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Abstract
Two histone marks, H3K27me3 and H3K9me3, are well 
known for their repressive roles in the genic and nongenic 
regions of metazoan genomes. Several protein complexes 
are known to be responsible for generating these marks, 
including polycomb repression complex 2 and several 
H3K9 methylases. Recent studies have shown that the 
targeting of these histone-modifying complexes within 
mammalian genomes may be mediated through several 
DNA-binding proteins, including AEBP2, JARID2, and 
YY1. In this review, we discuss the potential targeting 
mechanisms in light of the recent results that have been 
derived from genome-wide chromatin immunoprecipita-
tion sequencing data and the in vivo functions of these two 
histone marks in light of the results derived from mouse 
and human genetic studies.
Key Words: AEBP2; H3K9me3; H3K27me3; JARID2; 
PRC2; YY1 
Introduction
T wo histone marks, H3K27me3 (trimethylation on Lys 27 of histone 3) and H3K9me3 (trimethylation on Lys 9 of histone 3), are known for their roles related 
to repression in the genic and nongenic regions of meta-
zoan genomes. Several complexes are known to be respon-
sible for generating these marks, including polycomb 
group complexes and H3K9 methylases. However, the 
mechanisms by which these complexes are targeted are not 
well understood, although a number of hypotheses have 
been proposed to explain these targeting mechanisms. One 
mechanism would be through DNA-binding proteins, such 
as JARID2 and AEBP2 for H3K27me3 and other DNA-
binding proteins for H3K9me3, whereas the other mechanism 
recently discovered and proposed would be through noncod-
ing RNA (ncRNA1), which has been recently discovered 
and proposed. In this review, we summarize and discuss 
the fi rst mechanism, a DNA-binding protein–mediated tar-
geting mechanism, with the recent results that have been 
derived from genome-wide chromatin immunoprecipita-
tion sequencing (ChIP-Seq1) data, and we also discuss the 
in vivo functions of these histone modifi cation marks with 
the data derived from mouse and human genetic studies.
Genome-Wide Distribution of Histone 
Modifi cation Marks in Mammals
In the past several years, the genome-wide distribution of the 
histone marks H3K27me3 and H3K9me3 has been analyzed 
using ChIP techniques (Boyer et al. 2006; Lee et al. 2006; 
Mikkelsen et al. 2007). From these studies, the following 
conclusions about the genome-wide distributions of the two 
histone modifi cation marks can be derived. 
First, although these two marks are recognized as repres-
sive signals, these marks are found in different chromosomal 
regions. H3K27me3 is detected preferentially in gene-rich 
regions, which are traditionally defi ned as R-banding regions 
by Giemsa staining (Pauler et al. 2009). In particular, 
H3K27me3 is closely associated with a set of development 
regulators, estimated to be about 500 genes, in embryonic 
stem cells (Boyer et al. 2006; Lee et al. 2006). The list of 
these genes includes Hox, Pax, and Sox gene family mem-
bers, which are expressed during animal development, but 
not in pluripotent embryonic stem cells. In a given gene, the 
promoter region is usually marked with this histone modifi -
cation, which shows CpG-rich sequence structures (Ku et al. 
2008). In contrast, H3K9me3 is detected preferentially in 
gene-poor regions, which are traditionally defi ned as 
G-banding regions by Giemsa staining (Pauler et al. 2009). 
These regions include satellite repeats in telomeres and peri-
centromeres, which show tandem repeat sequence struc-
tures. H3K9me3 is also detected in several families of 
retrotransposons that have been amplifi ed through RNA-
mediated mechanisms in vertebrate genomes. These ret-
rotransposons with H3K9me3 include long interspersed DNA 
1Abbreviations that appear ≥3x throughout the article: ChIP-Seq, chromatin 
immunoprecipitation sequencing; LTR, long terminal repeat; ncRNA, 
noncoding RNA; PRC2, polycomb repression complex 2; RNAi, RNA 
interference.
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elements and long terminal repeats (LTRs1) (Mikkelsen et al. 
2007). H3K9me3 is also found in one particular gene family, 
Kruppel-type zinc fi nger genes, the coding regions of which 
show tandem repeat sequence structures (Blahnik et al. 2011). 
Thus, H3K9me3 marks are overall closely associated with 
tandem repeat sequences, whereas H3K27me3 marks are 
associated with CpG-rich sequences. 
Second, these histone marks are much more prevalent 
during early embryonic stages, but they become less preva-
lent once embryonic stem cells are differentiated into so-
matic cells. In most genomic regions, these early histone 
modifi cation signals are changed into more permanent re-
pression signals, such as DNA methylation (Meissner et al. 
2008). This transition from histone to DNA modifi cations 
also appears to be different between the two histone modifi -
cation marks. In the case of H3K27me3, the majority of the 
genomic regions with this mark is usually protected from 
DNA methylation. On the other hand, the regions with 
H3K9me3 are methylated in somatic cells. In summary, 
H3K27me3 is regarded as a temporary repression signal that 
is designed for controlling a set of development regulators. In 
contrast, H3K9me3 is considered to be a permanent repres-
sion signal that is designed for the heterochromatin formation 
of chromosomal regions with tandem repeat structures.
Modifying Complexes
The H3K27me3 mark is established by a protein complex 
called polycomb repression complex 2 (PRC21). In the past 
decade, there have been numerous attempts to biochemically 
purify PRC2 (Cao and Zhang 2004; Li et al. 2010; Pasini 
et al. 2010; Peng et al. 2009; Shen et al. 2009). These studies 
have shown that the following proteins are considered core 
components for PRC2 based on their co-occurrence in the 
independent purifi cation attempts: EZH2, EED, SUZ12, and 
RbAp46/48. EZH2 is the enzyme modifying H3K27, and 
EED is the adaptor protein connecting all the other compo-
nents. The exact molecular functions of SUZ12 and 
RbAp46/48 are still unclear, but these two proteins are known 
to enhance the enzymatic activity of EZH2. These core com-
ponents of PRC2 are conserved among all the higher eu-
karyotes, including insects, vertebrates, and even plants 
(Schuettengruber et al. 2007). This conservation is consistent 
with the fact that H3K27me3 is one of the earliest histone 
modifi cation marks that have appeared during eukaryotes’ 
evolution. Besides the core components, recent studies 
have also identifi ed two DNA-binding proteins, AEBP2 and 
JARID2, as PRC2-interacting components (Li et al. 2010; 
Pasini et al. 2010; Peng et al. 2009; Shen et al. 2009). Simi-
larly, the two DNA-binding proteins are also conserved among 
all metazoans, ranging from insects to mammals (Kim et al. 
2009; Liu and Montell 2001). According to the expression 
profi les for the core components of PRC2, the majority of 
proteins are highly expressed during early embryonic stages, 
which is also consistent with the fact that H3K27me3 is the 
most visible within the embryonic stem cells. 
The H3K9me3 mark is known to be generated by sev-
eral enzymes, including SETDB1 (or ESET), SUV39H1, 
SUV39H2, EHMT1 (GLP), and EHMT2 (G9A). This is in 
stark contrast to the dominant role played by a single pro-
tein, EZH2, for the modifi cation of H3K27me3. This dif-
ference may be because H3K9me3 is more global and 
permanent than H3K27me3. Among these H3K9 methylases, 
SUV39H1 and SUV39H2 are responsible for establish ing 
H3K9me3 in constitutive heterochromatic, pericentro-
meric, and telomeric regions (Peters et al. 2001). In contrast, 
EHMT1 and EHMT2 are responsible for setting up 
H3K9me3 in euchromatic regions (Tachibana et al. 2002). 
On the other hand, SETDB1 is highly expressed in ES cells 
and identifi ed as a major regulator that is required for main-
taining the pluripotency and self-renewal properties of ES 
cells (Yeap et al. 2009; Yuan et al. 2009). 
The H3K9 methylases have also been found to interact 
with various proteins that may mediate recruitment to target 
genes. First, the interacting partners for SETDB1 include 
OCT4 in ES cells, suggesting that OCT4 might target 
SETDB1 to numerous genomic loci in ES cells (Yeap et al. 
2009; Yuan et al. 2009). SETDB1 also interacts with KAP-1, 
which is also known as TRIM28 (tripartite motif–contain-
ing 28) (Schultz et al. 2002). KAP-1/TRIM28 is a tran-
scriptional corepressor that interacts with a large number of 
Kruppel-type zinc fi nger proteins found in vertebrate ge-
nomes, estimated to be more than 500 genes per genome 
(Hamilton et al. 2003). Thus, the repressive function exerted 
by the vast majority of Kruppel-type zinc fi nger proteins is 
likely mediated through the interaction with KAP-1/TRIM28 
and SETDB1, establishing H3K9me3 at the various target 
loci of these Kruppel-type zinc fi nger proteins. Second, al-
though the main target loci of SUV39H1 and SUV39H2 are 
constitutive heterochromatic regions, these two methylases 
are also known to interact with several proteins, such as 
tumor suppressor RB and proto-oncoprotein EVI1, to re-
press individual gene loci (Ait-Si-Ali et al. 2004; Cattaneo 
et al. 2008). Third, EHMT2 interacts with several DNA-
binding proteins, including BLIMP-1, a regulator of pri-
mordial germ cell and B cell development, and GFI1, a 
repressor of the cell cycle regulator p21Cip/EAF (Duan et al. 
2005; Gyory et al. 2004). The major expression stages of 
these H3K9 methylases are also early embryonic stages 
similar to the core components of PRC2 for H3K27me3. 
Similar to PRC2, the homologues of these H3K9 methylases 
are also found in species ranging from insects to mammals, 
confi rming the evolutionary conservation of these methyl-
ases, as seen for the H3K27me3 mark. 
As described earlier, the histone marks H3K27me3 and 
H3K9me3 are very closely associated with DNA methyla-
tion, although a causal relationship between these two modi-
fi cations has not been well understood. Consistent with this 
close association with DNA methylation, several histone 
methylases are known to interact with DNA methylation ma-
chineries. First, EZH2 is known to interact with DNMT3A, 
DNMT3B, and DNMT1 (Viré et al. 2006). This interaction 
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genes. Second, EHMT2 is also known to interact with 
DNMT3A and DNMT3B through a protein subdomain 
called ankyrin, independent from the SET domain that is 
responsible for histone methylation (Epsztejn-Litman et al. 
2008). Several studies involving biochemical purifi cations 
indeed confi rmed that isolated multiprotein complexes usu-
ally contain both histone and DNA methylases (Cedar and 
Bergman 2009). This suggests that these complexes may 
have dual functions for nucleosomes—methylation on both 
histones and DNA (Cedar and Bergman 2009).
DNA-Binding Proteins and Targeting 
Mechanisms
In Drosophila, small genomic fragments, that are 60 to 100 
base pairs in length are known to bind and recruit PRC2, and 
these fragments contain a cluster of DNA-binding sites for 
several transcription factors—Pho (pleiohomeotic), Trl/GAF 
(Trithorax-like, also known as GAGA factor), Psq (Pipsqueak), 
Grh (Grainhead), and Zeste (Müller and Kassis 2006). Thus, 
it is believed that these DNA-binding proteins may work 
together to recruit PRC2. Similar mechanisms have been 
proposed for the targeting of vertebrate PRC2, and two 
DNA-binding proteins have been identifi ed as the targeting 
components for PRC2—AEBP2, and JARID2. 
According to the results from ChIP experiments, both 
proteins occupy a set of genomic loci that are bound by the 
components of PRC2, further confi rming that these two pro-
teins are components of PRC2 (Kim et al. 2009; Li et al. 
2010; Pasini et al. 2010; Peng et al. 2009; Shen et al. 2009). 
Because these two proteins have DNA-binding capability, 
these two proteins are predicted to function as targeting pro-
teins for PRC2 (Figure 1). Both proteins are known to bind 
to the genomic regions that contain CpG-rich and GAGA 
motif–rich sequences (Kim et al. 2009; Peng et al. 2009). 
The binding of the two proteins to CpG-rich sequences is 
consistent with the fact that many H3K27me3-marked re-
gions are in the CpG-rich promoter regions of development 
regulators. The binding to GAGA motifs is also noteworthy 
because similar motifs have been frequently identifi ed as 
part of polycomb responsive elements in Drosophila. 
Although another DNA-binding protein called Trl/
GAF(GAGA factor) is known to bind to the GAGA motif in 
fl ies, it will be interesting to test whether the insect homo-
logues of AEBP2 and JARID2 also bind to the known poly-
comb responsive elements (Kim et al. 2009; Liu and Montell 
2001). Several independent groups recently tested the potential 
targeting function of JARID2 in mouse ES cells. Interestingly, 
the results are somewhat inconsistent and con troversial. 
RNA interference (RNAi1)–based reduction of JARID2 re-
sulted in either no change or somewhat increased levels of 
H3K27me3 at the genomic loci that are targeted by PRC2 
(Li et al. 2010; Peng et al. 2009; Shen et al. 2009). Although 
more detailed studies remain to be done, this might be an 
indication that JARID2 fi ne-tunes the levels of H3K27me3 
for a given locus depending upon the development contexts 
of cells and tissues. In mutant mice in which the transcrip-
tion of Aebp2 was disrupted by a knock-in allele, the hetero-
zygotes provided a similar result as seen in the RNAi-based 
experiments of JARID2, causing increased levels of 
H3K27me3 (Kim et al. 2011). This unexpected outcome is 
also controversial at the moment. Nevertheless, there is no 
doubt that the most obvious role of these two proteins for 
PRC2 should be DNA binding, although the exact functional 
context of this DNA binding remains to be investigated.
Several DNA-binding proteins are known to be associ-
ated with H3K9 methylases, including OCT4, RB, EVI1, 
and GFI1, but the targeting function of these DNA-binding 
proteins is likely limited to a small number of genes because 
the vast majority of genomic loci marked with H3K9me3 are 
tandem repeats. Also, the sequences of tandem repeats are 
quite different from the binding motifs for these proteins. 
If some DNA-binding proteins are involved in the targeting 
of H3K9me3 to the tandem repeats, those proteins should 
have binding capability with tandem repeats and also some 
connection to H3K9me3 modifi cation. 
The protein YY1 fi ts these criteria based on the follow-
ing reasons. First, YY1 is known to bind to -satellite re-
peats, which are found as part of the pericentromeric repeats 
of the mouse genome (Shestakova et al. 2004). Also, many 
families of retrotransposons that are marked with H3K9me3, 
such as long interspersed DNA elements and LTRs, have the 
DNA-binding sites for YY1 (Khan et al. 2006; Satyamoorthy 
et al., 1993). In fact, because many repeats tend to have the 
DNA-binding sites for YY1, YY1 has been recognized as a 
surveillance gene that represses transcriptional noise from 
the vertebrate genomes (Shi et al. 1997). Second, according 
to the results of YY1 ChIP-Seq data (Mendenhall et al. 
2010), many binding sites for YY1 overlap with the peaks of 
H3K4me3, but not with those of H3K27me3, which is some-
what contradictory to the long-standing prediction that YY1 
may be a targeting protein for PRC2 (Atchison et al. 2003; 
Wilkinson et al. 2006). It is, however, important to note that 
two duplicated copies of YY1—REX1 and YY2 (Kim et al. 
2007)—are known to interact with EED, a component of 
PRC2. Thus, it is still possible that REX1 or YY2 might re-
cruit PRC2 in ES cells (Garcia-Tuñon et al. 2011). Neverthe-
less, some YY1 binding sites overlap very well with the 
peaks of H3K9me3. Furthermore, these genomic loci are 
-satellites or retrotransposons, further supporting the pos-
sibility that YY1 might be involved in the targeting of 
H3K9me3 to repetitive regions. Third, although YY1 has 
long been predicted to be a targeting protein for PRC2, re-
cent studies revealed that YY1 is a component of a newly 
discovered polycomb complex, termed PhoRC (Pho repres-
sive complex) (Klymenko et al. 2006). The main compo-
nents of this complex are Pho (YY1 homologue in fl ies) and 
another PcG protein called dSFMBT (Scm-related gene con-
taining four MBT domains). SFMBT is a well-known repres-
sor that recognizes H3K9me1 or K3K9me2 (Klymenko et al. 
2006). This again supports the potential connection be-
tween YY1 and H3K9me3. Fourth, conditional knockdown 
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complete depletion of H3K9me3 in developing sperm in the 
mouse (Wu et al. 2009). These in vivo data suggest that YY1 
may be involved in establishing H3K9me3 in germ cells. In 
summary, the observations described above strongly support 
the idea that YY1 may be involved in the establishment of 
H3K9me3.
In terms of detailed mechanisms, YY1’s role in 
H3K9me3 is predicted to be quite different from the mecha-
nism proposed for PRC2, by which DNA-binding proteins, 
such as AEBP2 and JARID2, bind and recruit the histone-
modifying complex. This model is impossible in the case of 
H3K9me3 because there are a greater number of tandem re-
peats that need to be marked by H3K9me3 than available 
protein molecules of YY1. One feasible scenario is illus-
trated in Figure 1. YY1 might bind to a small number of the 
tandem repeats, but not all of them, and trigger the modifi ca-
tion process of H3K9me3, which in turn spreads over all tan-
dem repeats or retrotransposons. One candidate molecule for 
transforming the initial marking to genome-wide marking 
could be small RNAs. It is well known that small RNAs tran-
scribed from pericentromeric repeats are used for recruiting 
epigenetic machinery in plants, including H3K9 methylases 
and DNA methylases (Martienssen et al. 2008). Although 
similar mechanisms have not been identifi ed so far for the 
vertebrate genomes, recent studies revealed that small RNAs 
derived from LTRs, such as Piwi-interacting RNA, are re-
sponsible for the transcriptional repression of LTRs and 
Figure 1 Potential targeting mechanisms for polycomb repression complex 2 (PRC2) and H3K9 methylases. The CpG-rich promoters of 
development regulators are fi rst recognized by AEBP2 and/or JARID, and subsequently PRC2 is recruited to these target loci, resulting in 
trimethylation on H3K27. In contrast, the tandem repeats or retrotransposons are fi rst recognized by YY1 and transcribed by Pol II. The 
repeat-driven transcripts are further processed and later used for the targeting of H3K9 methylases, resulting in trimethylation on H3K9 in 
the tandem repeats and retrotransposons. Once a given genomic region is marked by H3K27me3 or H3K9me3, that region becomes transcrip-
tionally silent by a series of other follow-up events, including recruitment of PRC1 (H3K27me3) and HP1 (H3K9me3). 
other retrotransposons through DNA methylation (Saito et 
al. 2006; Watanabe et al. 2006). It is still unclear how these 
small RNAs are generated. However, given the ubiquitous 
presence of YY1 binding sites in many retrotransposons, it is 
feasible to predict that YY1 might trigger this initial tran-
scription from the tandem repeats and LTRs, which are then 
processed into Piwi-interacting RNAs. Finally, these Piwi-
interacting RNAs might be used to recruit H3K9 methylases 
to the tandem repeats or retrotransposons. Consistent with 
this, some of the pericentromeric repeats in the mouse are 
known to be transcribed in dividing cells (Lu and Gilbert 
2007). In summary, several lines of evidence are consistent 
with the hypothesis that YY1 is involved in establishing 
H3K9me3, and thus it will be of great interest to test the 
mechanism of YY1 as a triggering factor for the establish-
ment of H3K9me3.
Besides the proposed targeting mechanisms for PRC2 
and H3K9 methylases, several other mechanisms are also 
likely, based on the following reasons. First, many loci with 
H3K9me3 show tandem repeat sequence structures, but they 
do not show any sequence similarity among themselves. 
This suggests that the repeat structure itself, not the se-
quence, might be important for the recognition by H3K9 
methylases. Second, recent studies have identifi ed ncRNAs 
as possible targeting molecules for PRC2. These exemplary 
studies have been derived from the Hox and Xist loci (Rinn 









tr user on 29 Septem
ber 2021
236 ILAR Journal
are required for the targeting of PRC2 and subsequent 
H3K27me3 establishment. In fact, EZH2 has been shown to 
be the protein that interacts with these ncRNAs (Zhao et al. 
2008). Similar observations have also been derived for one 
H3K9 methylase, EHMT2. According to the results from 
two imprinted loci, Igf2r and Kcnq1, the ncRNAs from these 
imprinted loci are also required for the targeting of EHMT2 
and subsequent establishment of the allele-specifi c H3K9me3 
(Nagano et al. 2008; Redrup et al. 2009). In summary, these 
observations suggest that there are likely multiple potential 
targeting mechanisms for PRC2 and H3K9 methylases and 
they potentially act through both DNA-binding proteins and 
ncRNAs. 
Functional Consequences Associated with 
Defects in Histone-Modifying Complexes
Genome-wide profi ling of the histone marks H3K27me3 
and H3K9me3 clearly identify the two different genomic re-
gions that are marked by these modifi cations, providing im-
mediate hints for the potential functions of these marks at the 
genomic level. On the other hand, the biological processes in 
which these marks are important can be inferred from the 
cellular- and organism-level phenotypes produced by muta-
tions of the histone-modifying complexes responsible for 
these marks. According to the results derived from PRC2, 
complete or near-complete depletion of the core components 
of PRC2 in ES cells usually causes unscheduled differentia-
tion of ES cells, suggesting that PRC2 plays a role in main-
taining the pluripotency and self-renewal properties of ES 
cells (Margueron and Reinberg 2011; Schuettengruber and 
Cavalli 2009). Similar experiments using ES cells were con-
ducted to test the function of H3K9 methylases. Depletion of 
SETDB1 causes the induction of several key genes for the 
trophectoderm lineage in ES cells, resulting in differentia-
tion into trophectoderm cells (Yeap et al. 2009; Yuan et al. 
2009). These results confi rm that, besides constitutive het-
erochromatic regions, many developmental regulators lo-
cated in euchromatic regions are also subject to the 
H3K9-mediated repression (Bilodeau et al. 2009; Lohmann 
et al. 2010). Deletion of SETDB1 in ES cells also causes de-
repression of a large number of endogenous retroviruses, 
supporting the fact that many retrotransposons are repressed 
by H3K9me3 (Matsui et al. 2010). This is also the case for 
KAP-1, an interacting partner of SETDB1: deletion of 
KAP-1 in ES cells de-represses a large number of endoge-
nous retroviruses in the mouse genome (Rowe et al. 2010).
In the past decade, the core components of PRC2 and 
several H3K9 methylases have been mutated in the mouse, 
and subsequently the in vivo roles of these genes have been 
analyzed. Results from breeding experiments have shown 
that embryos homozygous for the mutant alleles of each 
PRC2 component are usually lethal around the implantation 
stage, mainly because of a failure to establish the three germ 
layers. This suggests that PRC2 is required for lineage speci-
fi cation (Faust et al. 1995; O’Carroll et al. 2001; Pasini et al. 
2004). The homozygotes for some H3K9 methylase mutants 
are also embryonic lethal but at different stages of embry-
onic development. The homozygotes for SetDB1 die between 
3.5 and 5.5 days postcoitum, whereas the homozygotes for 
Ehmt2 survive up to 8.5 days postcoitum (Dodge et al. 2004; 
Tachibana et al. 2002). In the case of Suv39h1 and Suv39h2, 
the homozygotes for single-gene knockouts are viable, but 
the double homozygotes for both genes are lethal around 
13.5 days postcoitum (Peters et al. 2001). DNA methylation 
analyses with these surviving embryos revealed that the peri-
centromeric repeats are hypomethylated, further support-
ing the close association between these H3K9 methylases 
and DNA methylation machineries. The homozygotes for 
Ehmt2, Suv39h1, and Suv39h2 show embryonic lethality 
at relatively later stages than those for PRC2, potentially 
caused by functional redundancy between different H3K9 
methylases. On the other hand, the heterozygotes for the 
mutants described above are usually viable within the 
Mendelian ratios, but some fraction of these heterozygotes 
also show visible phenotypes, such as reduced growth rates 
and defects in neurulation (Miró et al. 2009). However, the 
actual causes for these phenotypes are currently unknown.
In placental mammals, H3K27me3 and H3K9me3 his-
tone modifi cation marks are also part of the main repression 
mechanisms for genomic imprinting and X chromosome in-
activation. First, in genomic imprinting, small genomic re-
gions function as imprinting control regions, which control 
the allele-specifi c expression and DNA methylation of the 
surrounding imprinted genes (Bartolomei 2009). Interest-
ingly, the known imprinting control regions tend to show 
tandem repeat structures (Kim 2008) and, furthermore, are 
marked by H3K9me3 in ES cells (Mikkelsen et al. 2007). 
This is very unusual because many CpG-rich promoter re-
gions are usually marked by H3K4me3 and/or H3K27me3 
in ES cells (Mikkelsen et al. 2007). Nevertheless, it is inter-
esting to point out the presence of a similar pattern, tandem 
repeats with H3K9me3, between the imprinting control re-
gions of imprinted regions and the tandem repeats of hetero-
chromatic regions. It is unclear which proteins are responsible 
for establishing this histone modifi cation on the known im-
printing control regions. However, two H3K9 methylases are 
likely involved based on the following observations. RNAi-
based knockdown of SETDB1 results in the removal of 
H3K9me3 and subsequent induction of several imprinted 
genes in ES cells, suggesting potential roles for SETDB1 in 
genomic imprinting (Yuan et al. 2009). Also, EHMT2 has 
been shown to be involved in setting up H3K9me3 on the 
Igf2r- and Kcnq1-imprinted domains, which is again re-
quired for maintaining the imprinting of these two domains 
(Nagano et al. 2008; Redrup et al. 2009). Second, a large 
fraction of imprinted genes are imprinted only in the pla-
centa, yet these genes are usually marked with allele-specifi c 
H3K27me3, not with DNA methylation (Lewis et al. 2004; 
Umlauf et al. 2004). This observation was fi rst noticed in the 
mutant mice targeting Eed (Mager et al. 2003). Many im-
printed genes in the Eed mutant are deregulated in terms of 
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EED is the core component for PRC2 responsible for 
H3K27me3. Besides this involvement, PRC2 is also required 
for X chromosomal inactivation in female mammals. During 
the early stages of X chromosomal inactivation, PRC2 has 
been shown to be recruited to the inactivating X chromo-
some for the establishment of H3K27me3 (Plath et al. 2004).
In humans, there are several diseases or disease states that 
are closely associated with defects in the components of PRC2 
and H3K9 methylases. First, human EZH2 has been identifi ed 
as an overexpressed gene in metastatic prostate cancers, sug-
gesting its involvement in the progression of prostate cancers 
(Varambally et al. 2002). EZH2 is also considered to be a tu-
mor suppressor based on the observation that loss-of-function 
type mutations are frequently associated with myeloid disor-
ders (Ernst et al. 2010). Second, human SUZ12 is frequently 
identifi ed as part of chimeric transcripts resulting from the re-
current translocation between human chromosomes 7 and 17 
in endometrial stromal tumors (Koontz et al. 2001). Third, re-
cent results indicate that improper establishment of H3K9me3 
on tandem repeats might be responsible for human diseases. 
Facioscapulohumeral dystrophy is usually caused by the con-
traction of a repeat, termed D4Z4 located in human chromo-
some 4q. In a minor group of facioscapulohumeral dystrophy, 
a loss of SUV39H1-mediated H3K9me3 is likely related to 
the misexpression of the nearby genes that are involved in 
muscle development (Zeng et al. 2009). There are many hu-
man diseases that are associated with tandem repeat expan-
sion, such as the GAA repeat expansion in Friedreich’s ataxia, 
and H3K9me3 involvement in the etiology of these diseases is 
currently unknown. However, the expansion of tandem re-
peats and subsequent spreading of H3K9me3 to nearby genes 
could be one feasible path for these repeat-associated diseases 
(Al-Mahdawl et al. 2008). 
Conclusion
Owing to technical advances, such as next-generation se-
quencing technology, a large amount of genomic data about 
the epigenetic modifi cation of human and other mammalian 
genomes has been obtained. These results indicate that the 
histone modifi cation marks H3K27me3 and H3K9me3 play 
very important roles in mammalian genome regulation. Also, 
we have been able to identify protein complexes that are re-
sponsible for producing these histone modifi cation marks, in-
cluding PRC2 and several H3K9 methylases. Intriguingly, 
some of the components for these complexes have been iden-
tifi ed as disease genes that are closely associated with cancers 
or genetic disorders, further supporting the signifi cant roles 
played by these histone modifi cation marks. So far, much 
progress has been made in understanding these repression sig-
nals, but the following aspects remain to be investigated. First, 
the targeting mechanisms for both PRC2 and H3K9 methyl-
ases are not fully understood. In that regard, it would be very 
interesting to focus on the two newly identifi ed DNA-binding 
proteins for PRC2—AEBP2 and JARID2—and also on YY1 
for possible roles in the targeting of H3K9me3. The most 
important questions for these proteins are: (1) Are these pro-
teins responsible for the targeting of PRC2 and H3K9 methyl-
ases? If so, then (2) what are the exact functions of each of 
these proteins for the histone-modifying complexes? Second, 
although the two histone marks have been mainly recognized 
as transcription repressors, these marks might have some 
functions other than transcription. For instance, H3K9me3 is 
mainly detected in the genomic regions with tandem repeats, 
which are well known for duplication through crossover. The 
H3K9me3-mediated heterochromatin formation might be 
designed for blocking potential illegitimate crossover to 
preserve genomic stability. This possibility was previously no-
ticed in the phenotype of the Suv39h1 and Suv39h2 mutant 
mice, which exhibit a high degree of genomic instability 
(Peters et al. 2001). Third, recent data from personal genome 
sequencing indicate that many human disorders tend to have 
mutations on the genes that are involved in epigenetic setting 
(Ernst et al. 2010). Although the homozygotes for any muta-
tion in PRC2 and H3K9 methylases are not viable, as demon-
strated in several mouse models, the heterozygotes for these 
mutations are likely viable and display altered phenotypes. In 
this regard, it is important to note that there are many adult 
stem cells that require the function of PRC2 for their pluripo-
tency and self-renewal properties. In a heterozygous individ-
ual with a mutation, suboptimal levels of enzymatic activity 
for either H3K27me3 or H3K9me3 modifi cation could easily 
cause disease states for this very vulnerable population of 
adult stem cells. In summary, although we need to wait for 
more data from the future experiments described above, it is 
very clear that these two histone modifi cation marks are major 
repression signals in the development processes of humans 
and other mammals. 
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